Quantumscape Corp.'s stock plummeted 5.02% during intraday trading on Wednesday, reflecting investor concerns ahead of the company's upcoming earnings report.

The decline follows an earnings preview indicating that Quantumscape's Q4 revenue is expected to be minimal, with the company still in pre-commercialization stages and no commercial revenue yet recognized. Analyst views are described as cautiously neutral-to-bearish, emphasizing execution risks and the absence of near-term revenue catalysts.

The preview notes that while the company's EPS and EBIT are projected to show year-over-year improvement, the continued expectation of zero revenue constrains valuation support in the short term. Investors appear to be reacting to these cautious outlooks and the heightened focus on the company's progress toward commercialization milestones.